Pulike set to take control of Zhongpu Biotech with new equity acquisition

Pulike Biological Engineering (Pulike) intends to acquire a 4.04% equity stake in Zhongpu Biotechnology Co., Ltd. (Zhongpu Biotech) from CITIC Agriculture Technology Co., Ltd. The transaction, valued at 17,514,300 yuan, aims to improve Zhongpu Biotech's operational status and secure Pulike's controlling interest.

Zhongpu Biotech, established in June 2018, primarily focuses on foot-and-mouth disease vaccine operations. Prior to this transaction, Pulike held a 46.97% stake, while Zhongmu Industrial Co., Ltd. held 48.99%, and CITIC Agriculture held 4.04%. The acquisition capitalizes on Pulike's preferential right to purchase the shares, with Zhongmu Industrial consenting to lift previous restrictions.

Zhongpu Biotech reported total assets of 330,103,300 yuan and a net profit of -18,237,000 yuan for the first half of 2025.